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E-mail address: marco.hagenmueller@med.uni-heidCardiac myocyte growth is under differential control of mammalian target of rapamycin (mTOR)
and glycogen-synthase-kinase-3b (GSK3b). Whereas active GSK3b negatively regulates growth and
down-regulates cellular protein synthesis, activation of the mTOR pathway promotes protein
expression and cell growth. Here we report that depletion of mTOR via siRNA mediated knockdown
causes marked down-regulation of GSK3b protein in cardiac myocytes. As a result, GSK3b target pro-
tein b-catenin becomes stabilized and translocates into the nucleus. Moreover, mTOR knockdown
leads to increase in cardiac myocyte surface area and produces an up-regulation of the fetal gene
program. Our ﬁndings suggest a new type of convergence of mTOR and GSK3b activities, indicating
that GSK3b-dependent stabilization of b-catenin in cardiac myocytes is inﬂuenced by mTOR.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction on AMP kinase (AMPK)-mediated priming phosphorylation.Cardiac hypertrophy is an adaptive response to an increased
workload of the heart. The enlargement of the heart muscle is pre-
dominantly a result of an increased size of individual cardiomyo-
cytes and is not controlled by proliferation [1]. Although a recent
study from Bergmann et al. provides evidence that cardiomyocytes
are able to renew, it is not clear whether this renewal is due to car-
diomyocyte proliferation or stem cell differentiation [2]. Cell
growth and proliferation are subjected to many intracellular con-
trol points. Mammalian target of rapamycin (mTOR) and glyco-
gen-synthase-kinase-3b (GSK3b) are crucial cellular modulators
of protein synthesis and cell growth, but apparently have contrary
roles. Among other functions GSK3b acts as an important negative
regulator of cellular protein synthesis [3], while activation of mTOR
promotes protein expression and cell growth [4].
Although mTOR and GSK3b operate in different signaling path-
ways possible points of convergence have been described. Under
low cellular energy conditions GSK3b, a constitutively active ser-
ine/threonine kinase, inhibits the mTOR pathway by phosphory-
lating tuberous sclerosis complex (TSC2). This activity dependschemical Societies. Published by E
Cardiology, Angiology and
r Feld 410, 69120 Heidelberg
elberg.de (M. Hagenmueller).Hyperphosphorylated TSC2 has an increased activity and acts as
a GTPase activating protein on Rheb, thereby inhibiting mTOR
activated cell growth [5]. In response to Wnt signaling, mTOR is
activated through inhibition of GSK3b [6]. Moreover, in this path-
way active GSK3b is a component of the destruction complex
consisting of GSK3b, adenomatous polyposis coli (APC), casein ki-
nase 1 (CK1) and the scaffolding protein Axin. This complex con-
tinuously phosphorylates b-catenin, thus activating its
degradation through the ubiquitin system. In turn, activation of
Wnt signaling pathway disrupts the destruction complex via
dishevelled (Dvl) and thereby stabilizes b-catenin, enabling its
translocation into the nucleus and interaction with transcription
factors of the TCF/LEF family. This activity ﬁnally induces the
expression of a number of growth promoting genes such as c-
myc and PPARd [7]. Furthermore, Haq et al. described Wnt inde-
pendent stabilization of b-catenin and consecutive myocyte
hypertrophy after inhibition of GSK3b [8]. Both mTOR and GSK3b
play major roles in the cellular response to insulin stimulation via
PI3K/Akt pathway [9]. Insulin stimulates protein synthesis by pro-
moting phosphorylation of the eIF4E-binding protein, 4EBP1. This
rapamycin-sensitive effect is mediated by mTOR [10]. GSK3b
activity decreases after insulin stimulation. This relieves the inhi-
bition of glycogen synthase and leads to glycogen synthesis. The
regulation of insulin response of mTOR as well as GSK3b is med-
iated by protein kinase B (PKB/Akt) [11].lsevier B.V. All rights reserved.
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activity via siRNA mediated knockdown on cardiac myocyte
growth and its implications for intracellular signal transduction.
2. Methods
2.1. Primary cultures of ventricular cardiac myocytes
Primary cultures of ventricular cardiac myocytes were prepared
from 1–3-day-old BR-Wistar rats (Charles River Laboratories) and
puriﬁed using a discontinuous Percoll gradient. Cells were cultured
in cardiac myocyte culture medium containing Dulbecco’s modi-
ﬁed Eagle’s medium (DMEM)/F-12 supplemented with 5% horse
serum, 4 lg/mL transferrin, 0.7 ng/mL sodium selenite, 2 g/L bo-
vine serum albumin (fraction V), 3 mM pyruvic acid, 15 mM
HEPES, 100 lM ascorbic acid, 100 l/mL ampicillin, 5 lg/mL linoleic
acid and 100 lM 5-bromo-20-deoxyuridine. We obtained cultures
in which more than 95% of cells were myocytes. Culture medium
was changed to serum-free at 24 h. The investigation was carried
out in accordance with the Guide for the Care and Use of Labora-
tory Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996) and was approved by
the local animal ethics review board (Approval No. 40631).
2.2. siRNA transfection
For at least 5 h myocytes were cultured in serum and antibiotic
free medium. For transfection of 2  106 cardiac myocytes in a
6 cm dish 250 pmol siRNA was diluted in 650 lL serum- and anti-
biotic free OptiMEM (Invitrogen). In another tube 4.5 lL of Lipofec-
tamin 2000 (Invitrogen) was diluted in 200 lL OptiMEM and
incubated for 5 min. After complex formation the solution and
OptiMEM were added to the cells. The cells were incubated for
72 h at 37 C. siRNAs used were mTOR 50-CUUCGAGACAUGAGU-
CAGCUUTT-30, GSK3b 50-UAACGCCGCUUCUGCAUCATT-30 and
non-speciﬁc control siRNA 50-AGGUAGUGUAAUCGCCUUGTT-30. In
all siRNA mediated knockdown experiments myocytes transfected
with non-speciﬁc (scrambled) siRNA were used as controls. siRNAs
were synthesized by MWG (Ebersberg, Germany).
2.3. Western immunoblot analyses
Myocytes were washed twice with ice cold phosphate-buffered
saline and scraped from the culture dish. Cells were lysed and incu-
bated for 30 min in ice cold RIPA buffer containing 150 mM NaCl,
50 mM Tris (pH 7.5), 0.5% deoxycholic acid, 1% NP-40, 0.1% sodium
dodecyl sulphate (SDS), 1 mM Na3VO4, 10 mM NaF and protease
inhibitors AEBSF 0.5 mM, aprotinin 5 lg/mL, Leupeptin 5 lg/mL.
Protein concentration was measured using BCA protein assay
(Interchim). Equal amounts of protein were separated with SDS–
PAGE and transferred to a nitrocellulose membrane (Milipore).
The membranes were incubated overnight at 4 C with a primary
antibody. Antibodies used were anti-mTOR, anti-Phospho-p70S6
Kinase (Thr389), anti-p70S6 Kinase, anti-ubiquitin, anti-HDAC1
(Cell Signaling Technology), anti-GSK3b (BD), anti-b-catenin (Santa
Cruz) and anti-a-actin (Sigma–Aldrich). Anti-rabbit IgG and anti-
mouse IgG horseradish peroxidase-conjugated antibodies (Cell Sig-
naling Technology) were used as secondary antibody. Bands were
quantiﬁed by densitometry using the Image J program.
2.4. Immunoprecipitation
Whole cell lysates were prepared as described above. Protein
concentration was measured using BCA protein assay (Interchim).
About 100 lg of cell lysates were incubated with anti-GSK3b anti-body (250 lg/mL) overnight at 4 C. At least 3 h after addition of
Protein-G-Agarose (Roche) samples were washed three times with
RIPA buffer. Samples were analyzed by immunoblotting using anti-
GSK3b (BD Biosciences) and anti-ubiquitin (Cell Signaling Technol-
ogy) speciﬁc antibody.
2.5. Quantitative real-time PCR
Total RNA was isolated from cardiac myocytes using the Trizol
reagent (Invitrogen). cDNA was synthesized with Revert Aid First
strand cDNA synthesis kit (Fermentas). The copy numbers of HPRT
housekeeping gene, GSK3b, b-catenin, c-myc, PPARd, ANF and b-
MHC were determined using the LightCycler system (Roche Diag-
nostics). Primers and speciﬁc probes were designed using the Rat
Universal Probe Library from Roche Diagnostics. Following primers
were used. For HPRT 50-GTCAAGGGGGACATAAAAG-30 and 50-
TGCATTGTTTTACCAGTGTCAA-30, probe #22; for GSK3b 50-CAG-
CTTTTGGTAGCATGAAAGTT-30 and 50-CAGGAGTTGCCACCACTGT-
30, probe #121; for b-catenin 50-GCAATCAGGAAAGCAAGCTC-30
and 50-TCAGCACTCTGCTTGTGGTC-30, probe #128; for PPARd 50-
GGACCAGAGCACACCCTTC-30 and 50-GAGGAAGGGGAGGAATTCTG-
30, probe #120; for c-myc 50-CCTAGTGCTGCATGAGGAGA-30and
50-TCTTCCTCATCTTCTTGCTCTTC-30, probe #75; for ANF 50-CAACA-
CAGATCTGATGGATTTCA-30 and 50-CCTCATCTTCTACCGGCATC-30,
probe #25 and for b-MHC 50-GAGGAGAGGGCGGACAT-30 and 50-
ACTCTTCATTCAGGCCCTTG-30, probe #95. All real-time PCR sample
reactions were normalized to HPRT mRNA expression. A standard
curve was run with the dilution series of the ampliﬁed fragment
allowing for mRNA copy number calculation.
2.6. Myocyte cell surface area
Myocytes were cultured on coverglasses and transfected with
siRNA as described. Four days after transfection myocytes were
washed twice with ice cold phosphate-buffered saline and ﬁxed
in PBS containing 4% paraformaldehyde for 30 min. For permeabi-
lization cell membrane cells were incubated for 10 min in phos-
phate-buffered saline containing 0.1% Triton X. Fixed cells were
blocked with 2% BSA in phosphate-buffered saline for 1 h. Immu-
nostaining was performed using Texas Red phalloidin (Molecular
Probes) and DAPI staining for 30 min. After staining coverglasses
were ﬁxed on microscope slides. For myocyte surface area micro-
scope images were captured by a digital camera. Analysis was per-
formed using the Image J program.
3. Results
3.1. siRNA mediated knockdown of mTOR decreases GSK3b protein
content and stabilizes b-catenin
Depletion of mTOR (83 ± 4%, P < 0.01 vs. control) via speciﬁc
siRNAwas associated with decreased phosphorylation of the mTOR
downstream target p70S6 kinase (35 ± 11%, P < 0.01 vs. control),
indicating an inhibition of the mTOR signaling pathway (Fig. 1A
and B). Since activation of mTOR leads to increased protein synthe-
sis and active GSK3b is a negative regulator of cell growth, we
hypothesized that knockdown of mTOR is associated with a com-
pensatory effect on GSK3b protein level. Indeed, in cardiac myocyte
cultures a reduction in GSK3b protein content compared to con-
trols was observed (33 ± 8%, P < 0.01 vs. control) (Fig. 2A and B).
By contrast, after GSK3b knockdown no difference in mTOR protein
content was noted (data not shown). In order to evaluate whether
reduced GSK3b is a consequence of lower GSK3b transcription we
measured mRNA levels. However, no signiﬁcant differences com-
pared to controls were detected. Therefore, assuming accelerated
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Fig. 1. Efﬁciency of siRNA mediated knockdown. (A) Shown is a representative Western Blot with mTOR, p70S6 and phospho-p70S6 speciﬁc antibodies. Cardiomyocyte
lysates were prepared 72 h after mTOR speciﬁc siRNA transfection. (B) Left bars indicate effective protein knockdown of mTOR. Data are presented as the mean and SEM from
three experiments in duplicate (*P < 0.01 vs. control). Right bars show reduction of phosphorylated mTOR downstream component p70S6 kinase, as a consequence of mTOR
knockdown. Graph shows mean and SEM from four individual experiments in duplicate (*P < 0.01 vs. control).
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Fig. 2. mTOR siRNA knockdown and effects on GSK3b. (A) About 72 h after siRNA transfection of cultured cardiac myocytes protein lysates were subjected to immunoblot
analysis with speciﬁc anti-mTOR and anti-GSK3b antibodies. Anti a-actin was used to control equal loading of SDS–PAGE. GSK3b protein content was decreased after mTOR
knockdown. (B) Graph shows mean and SEM of six individual experiments in duplicate of control and mTOR knockdown cardiomyocytes (*P < 0.01 vs. control). (C)
Degradation of GSK3b via Ubiquitin/Proteasom pathway. About 72 h after siRNA transfection 80 lg protein was utilized for immunoprecipitation with GSK3b speciﬁc
antibody. Western Blot and subsequent densitometric analysis was performed to determine the ratio of ubiquitinated GSK3b and total GSK3b. To avoid cross reaction with
immunoglobulins, antibodies from different species were used to detect GSK3b and Ubiquitin. Increase of Ub-GSK3b/GSK3b ratio in mTOR knockdown cells was observed.
Graph shows mean and SEM of three individual experiments in duplicate (*P < 0.05 vs. control).
76 M. Hagenmueller et al. / FEBS Letters 584 (2010) 74–80ubiquitin (Ub) mediated degradation of GSK3b, we performed fur-
ther mTOR knockdown experiments. Immunoprecipitation with
GSK3b speciﬁc antibody, followed by Western Blot analysis
showed an increase in Ub-GSK3b/GSK3b ratio (+240% ± 80%,
P < 0.05 vs. control) (Fig. 2C).
Next we investigated whether degradation of GSK3b after
mTOR knockdown affects target proteins of GSK3b. b-Catenin is
phosphorylated by GSK3b, leading to its degradation [8]. Activation
of Wnt signaling as well as inhibition of GSK3b leads to accumula-tion of b-catenin in the cytoplasm and its translocation into the nu-
cleus. This represents an important step to regulate target gene
transcription [12]. In concordance with these ﬁndings, we ob-
served that reduction of GSK3b after mTOR knockdown led to ele-
vation of levels of b-catenin in both cytoplasm (+159% ± 57%,
P < 0.01 vs. control) and nucleus (+53% ± 24%, P < 0.05 vs. control)
(Fig. 3A). In Wnt signaling b-catenin interacts with TCF/LEF and
thereby activates expression of c-myc and PPARd [13]. We deter-
mined whether b-catenin translocation into the nucleus involves
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Fig. 3. b-Catenin accumulation in the cytoplasm, translocation into the nucleus and expression of target genes. (A) About 72 h after mTOR siRNA or scrambled siRNA
transfection translocation of b-catenin into the nucleus was determined by immunoblotting of separated nuclear and cytoplasmic lysates using speciﬁc anti-b-catenin
antibody. HDAC-1 was used as loading control for nuclear-, a-actin for cytoplasmic lysates. Depletion of mTOR leads to increased b-catenin level in the cytoplasm and in the
nucleus. Bar Graph shows mean and SEM of four individual experiments in duplicate (**P < 0.01 vs. control; *P < 0.05 vs. control). (B) mRNA copy numbers of c-myc and PPARd
were analysed by real-time PCR. Graph shows mean and SEM of four individual experiments in duplicate (**P < 0.01 vs. control; *P < 0.05 vs. control). All measurements were
normalized to HPRT expression. Compared to controls, c-myc (left bars) and PPARd (right bars) mRNA expression in mTOR depleted myocytes were increased 72 h after mTOR
siRNA transfection.
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myc (+66 ± 9%, P < 0.01 vs. control) and PPARd (+63 ± 28%, P < 0.05
vs. control) (Fig. 3B) were detected.
3.2. mTOR knockdown elicits distinct features of cardiomyocyte
hypertrophy
It has been demonstrated that inhibition of GSK3b using GSK
inhibitor 1 or LiCl leads to increased cell size [14]. Furthermore,
activation of Wnt signaling stabilizes b-catenin and promotes cell
growth [15]. Due to the antihypertrophic effects of mTOR inhibi-
tion [16] we subsequently investigated the net effect of mTOR
knockdown on myocyte size. We found an increased cell surface
area (+44 ± 3%, P < 0.01 vs. control) (Fig. 4A) accompanied by in-
creased expression of fetal marker genes like ANF (+124 ± 35% vs.
control, P < 0.01) and b-MHC (+33 ± 8%, P < 0.05 vs. control)
(Fig. 4B), suggesting a potential role in the pathogenesis of cardiac
hypertrophy. Although myocyte surface area is increased and
hypertrophy markers such as ANF and b-MHC are up-regulated, to-
tal-protein content in mTOR knockdown cells was not increased,
compared to myocytes transfected with scrambled siRNA
(+5% ± 0.9%, P > 0.5) (Fig. 4C). In order to determine if this hypertro-
phic response is a result of attenuated GSK3b signaling, we carried
out GSK3b siRNA knockdown experiments (Fig. 4D). We found an
increased cell surface area (+32 ± 2%, P < 0.01 vs. control)
(Fig. 4A) as well as up-regulation of ANF (+72 ± 8%, P < 0.01 vs. con-
trol) and b-MHC (+42 ± 18%, P < 0.05 vs. control) under these con-
ditions (Fig. 4B).
Isoproterenol (ISO) is a potent stimulus to induce sarcomeric
reorganisation and hypertrophic growth in cardiac myocytes
[17]. We investigated whether stimulation of mTOR knockdown
myocytes with ISO (50 lM) increases hypertrophic response. Com-
pared to ISO stimulated control cardiomyocytes no signiﬁcant dif-
ference in myocyte surface area was observed (Fig. 5A). In
comparison to basal cultured mTOR knockdown cells, we found
an increased cell surface area in ISO stimulated mTOR knockdown
cells (+30 ± 5%, P < 0.05 vs. unstimulated mTOR knockdown cells).
Interestingly, stimulation of mTOR knockdown cells with ISO
(50 lM) did not lead to a stronger ANF expression. Compared to
non stimulated mTOR knockdown cells, ANF expression did not
further increase after ISO stimulation (Fig. 5B). No differences be-
tween control and mTOR knockdown cells cultured under basalconditions were observed as for sarcomeric organisation. In control
and mTOR knockdown cardiomyocytes, stimulation with ISO
(50 lM) leads to sarcomeric reorganization (Fig. 5C and D).
3.3. Rapamycin inhibition and siRNA mediated knockdown of mTOR
differentially affects downstream signaling
The anti-proliferative properties of rapamycin are frequently
used to investigate regulation of cell growth. Upon entering the
cytoplasm rapamycin forms a complex with FK506 binding protein
(FKBP12) and then rapamycin/FKBP12 binds to mTOR thereby
inhibiting its kinase activity [18]. In another set of experiments
we examined whether mTOR inhibition by rapamycin causes deg-
radation of GSK3b followed by stabilization of b-catenin as seen in
mTOR knockdown experiments. Phosphorylation of p70S6 kinase
was analyzed by immunoblotting to verify effectiveness of mTOR
inhibition by rapamycin (Fig. 6A). After pharmacological inhibition
of mTOR we measured protein levels of GSK3b and b-catenin by
immunoblotting. Unlike mTOR knockdown experiments in rapa-
mycin treated myocytes no difference in both GSK3b and b-catenin
protein levels were detected compared to controls (Fig. 6B).4. Discussion
In the present study we demonstrate that siRNA mediated
knockdown of mTOR in cardiac myocytes decreases GSK3b signal-
ing via the ubiquitin system. This results in accumulation of b-cate-
nin in the cytoplasm and increased nuclear translocation [19]. This
is not surprising since active GSK3b is known to phosphorylate b-
catenin, leading to an ubiquitin mediated degradation [20]. In our
study we did not observe an increase in the steady state level of b-
catenin transcripts, supporting the hypothesis that the increased
protein level is under post-translational control and does not result
from increased transcription. Concomitantly with the increase in b-
catenin we did observe increased gene expression of Wnt signaling
targets like c-myc and PPARd suggesting that Wnt components are
activated in reaction to inhibition of mTOR signaling. This may act
as a salvage pathway to protect cellular integrity. In addition, in-
creased myocyte area and intensiﬁed expression of hypertrophy
markers indicate a potential role of mTOR in development and reg-
ulation of pathological cardiac hypertrophy.
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Fig. 4. mTOR knockdown elicits distinct features of cardiomyocyte hypertrophy. (A) Myocyte surface area from cells transfected with scrambled siRNA (n = 630), mTOR siRNA
(n = 630) and GSK3b siRNA (n = 400) was determined 96 h after transfection and analyzed using Image J program. Bar graph shows mean and SEM from ﬁve individual
experiments of mTOR knockdown and four individual experiments of GSK3b knockdown. Both mTOR- and GSK3b knockdown cells indicate increased myocyte surface area
(*P < 0.01 vs. control). (B) 72 h after mTOR siRNA transfection total RNA was subjected to RT-PCR. Expression levels of ANF and b-MHCmRNA were normalized by that of HPRT
and expressed as 1 in unstimulated scrambled siRNA transfected myocytes. Bar graph shows mean and SEM from four individual experiments in duplicate (**P < 0.01 vs.
control; *P < 0.05 vs. control). In mTOR knockout cells both ANF and b-MHCmRNA expression were increased. Even cells treated with GSK3b siRNA show up-regulation of ANF
and b-MHC mRNA expression. (C) About 72 h after mTOR siRNA transfection, total protein was measured by BCA-assay. Protein content was normalized to DNA content
measured by Hoechst 33342 staining in a ﬂuorometer. Graph shows mean and SEM of three individual experiments in duplicate. Compared to controls, protein contend was
almost unchanged in mTOR knockdown cells. (D) Efﬁciency of GSK3b siRNA mediated knockdown. Depicted is a representative Western Blot from myocyte lysates prepared
72 h after GSK3b speciﬁc siRNA transfection. Bar graph indicates effective protein knockdown of GSK3b. Data are presented as the mean and SEM from three experiments in
duplicate (*P < 0.01 vs. control).
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sis it is fundamental for cells to maintain balance in GSK3b and
mTOR signaling activity. Our observations of decreased GSK3b pro-
tein level and stabilization of total cellular protein content after
mTOR knockdown suggest that such control is active. Without
any counter-regulatory mechanisms, mTOR knockdown would re-
duce global protein synthesis, and ﬁnally lead to cell death. Indeed,
our ﬁnding that knockdown of GSK3b does not affect mTOR protein
content suggests independent regulation for mTOR. Haq et al.
demonstrated that cardiac myocytes transfected with adenoviral
b-catenin, which can neither be phosphorylated by GSK3b nor
degraded via ubiquitin, show hypertrophic growth [8]. This is
supported by the results of our study, where we found increasedcardiac myocyte size in combination with stabilized b-catenin pro-
tein level. Based on our ﬁndings we propose that myocyte growth
and simultaneous elevated ANF and b-MHC expression is a result
of attenuated GSK3b signaling and concomitant stabilization of
b-catenin. This is further corroborated by GSK3b siRNA knockdown
experiments, where the same hypertrophic responses were ob-
served. Other essential features of cardiac hypertrophy were en-
hanced, namely the increase of cell surface area and the
induction of fetal gene program. Here it is of interest to note that
ANF expression is not further increased in mTOR knockdown cells
stimulated with ISO compared to mTOR knockdown cells cultured
under basal conditions, although an increase in myocyte size was
observed. Since mTOR knockdown leads to myocyte growth even
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Fig. 5. mTOR depletion and ISO stimulation. About 48 h after mTOR siRNA transfection cells were stimulated with 50 lM ISO for further 48 h. Relative myocyte area was
analyzed using Image J program. (A) Myocyte area of cells transfected with scrambled control siRNA (n = 630) and mTOR siRNA (n = 630) under basal conditions as well as
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were treated with or without 50 lM ISO for an additional 48 h. Total RNA was subjected to RT-PCR. Expression level of ANF was normalized by that of HPRT. Graph shows the
mean and SEM of four individual experiments with unstimulated cells and three individual experiments with ISO stimulated myocytes (*P < 0.01 vs. control). Up-regulation of
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80 M. Hagenmueller et al. / FEBS Letters 584 (2010) 74–80under basal conditions, mTOR may act as a critical regulator of
pathological cardiac hypertrophy.
Furthermore, our present study demonstrates that pharmaco-
logical inhibition of mTOR with rapamycin and siRNA mediated
knockdown of mTOR do not have exactly similar effects. Rapamy-
cin is a potent inhibitor of cardiac myocytes proliferation in vitro
[16] and is also able to inhibit cardiac myocyte hypertrophy [22].
While knockdown of mTOR is accompanied by degradation of
GSK3b as a compensatory step, which may stabilize b-catenin
and ﬁnally regulate cell growth, in rapamycin treated cells no
change in GSK3b and b-catenin protein content was observed.
Since mTOR exists in two complexes, namely TORC1 which is rap-
amycin sensitive and TORC2 which is not [23], our ﬁndings can be
explained by a predominant reduction of TORC2 following mTOR
knockdown. A recent study from Sarbassow et al. shows that phos-
phorylation of the mTOR upstream component Akt/PKB depends
on TORC2 in Drosophila [24].
In summary, siRNA mediated inactivation of mTOR pathway in
cardiac myocytes is not associated with growth restriction as it is
known from inhibition with rapamycin, but leads to a hypertrophic
response. mTOR knockdown also results in degradation of GSK3b
protein, stabilization of b-catenin and increased expression of its
target genes.
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